following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...
share on facebook facebook
.
amb. macharia kamau. however, bentley also warned that these treatments can be hazardous as they may cause bleeding which becomes more likely as the amount of svd increases.. would identify hospitals that are best positioned to treat strokes and establish protocols for emergency responders handling stroke patients..